Sanofi-Aventis (France) Continues Patent Fight with Jiangsu Hengrui
September 21, 2007 -- Sanofi-Aventis has once again taken Jiangsu Hengrui to court, for infringing on its patent for Docetaxel. Jiangsu Hengrui is one of the leading producers of cancer drugs in China. The two companies have been in various courts over Docetaxel for four years. More details...